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Factors across the life cycle, beginning before birth, influence breast 
cancer risk. We know this from epidemiologic studies of charac  teris­
tics self­reported by older women or gleaned from medical records. 
For example, larger babies have higher breast cancer risk decades 
later, and pre  eclampsia is associated with lower risk in daughters 
(Ruder et al. 2008; Xue and Michels 2007). Earlier puberty increases 
risk, and women with fewer or no pregnancies have higher risk later 
on (Bernstein 2002). These factors span sensitive periods of breast 
develop  ment, prenatally and during puberty and pregnancy (Rudel 
et al. 2011).
If environmental chemicals have comparable effects during sensi­
tive developmental periods, identifying these risks could lead to pre­
vention. However, epidemiologic data to assess the effects of chemicals 
in early life are rarely attainable. Exceptional events or decades­long 
cohort studies can provide some information. For example, studies 
of atom bomb survivors revealed breast cancer risk was highest from 
radiation exposure to young girls (Land 1995). A unique study using 
blood collected in the 1960s and stored for more than 40 years found 
higher breast cancer risk in women who were younger than 14 years 
of age when DDT was first put into use, taking advantage of a natural 
“experiment” (Cohn et al. 2007). But we cannot rely on observational 
chances like these to evaluate breast cancer risks for the many chemicals 
in use today. 
Thus, improving test methods in animals and cells is essential 
to identify chemicals that may interfere with breast development 
and contribute to cancer, so we can use this knowledge for primary 
prevention. These methods will extend recent changes in toxicity 
testing, which were designed to respond to research on endocrine­
disrupting compounds by evaluating how exposures in utero and 
during other windows of development set the stage for chronic 
diseases later in life. New procedures include dosing in utero and 
throughout development, adding morphological and functional 
assessments of reproductive organs, and including longer­term 
follow­up, none of which are included in traditional toxicity test­
ing. For example, new protocols recently demon  strated that in utero 
anti  androgen exposure in rodents leads to altered male reproductive 
develop  ment, as well as reduced fertility and possibly increased can­
cer later on. These observations are thought to parallel human “tes­
ticular dysgenesis syndrome,” which includes decreased fertility and 
increased incidence of cryptorchidism, hypo  spa  dias, and testicular 
cancer (Luccio­Camelo and Prins 2011). 
Mammary gland development has usually not been assessed in 
the new protocols, though. Yet, mounting evidence supports the 
importance of testing for breast effects for several reasons. The breast 
develops over a long period, with vulnerability beginning in utero 
and extending through the first pregnancy. For some chemicals 
tested to date, mammary gland development in males and females 
is altered at lower doses than the levels that cause changes in other 
tissues. The effects that have been observed after disrupted mam­
mary gland develop  ment include impaired lactation and increased 
susceptibility to cancer, so they are of potentially great public health 
significance. 
In this issue, three articles address these points: 
Makris (2011) reviews standard chemical testing protocols to identify 
gaps in mammary gland assessment. Key gaps include lack of early 
life exposure in tests for carcinogenic effects; lack of assessment of 
lactation function other than non  specific measures; and inadequate 
examination of mammary gland morphology and pathology.
Rudel et al. (2011) present a comprehensive review of hormone and 
chemical effects on mammary gland development, lactation, and 
cancer. Emerging from a meeting of 60 international experts, this 
article reports the majority opinion of this group that normal mam­
mary gland development and carcinogenesis are similar in rodents 
and humans; that chemical and hormone exposure in utero or early 
in life leads to altered mammary gland development; and that these 
changes may be risk factors for impaired lactation and cancer. Effects 
on mammary gland development are not limited to estrogenic endo­
crine disruptors but are induced by diverse chemicals, including 
perfluorinated compounds and the herbicide atrazine, in addition 
to the soy phyto  estrogen genistein and synthetic estrogens such as 
bisphenol A. 
White et al. (2011) demonstrate persistent effects of perfluoro  octanoic 
acid (PFOA) in drinking water on mouse mammary gland develop­
ment at exposures lower than in some contaminated drinking water 
supplies. 
Research needs identified in the articles include a call for dos­
ing during development; improved assessment of mammary gland 
develop  ment, structure, and function; and increased assessment 
of the male mammary gland. These recom  menda  tions have been 
implemented by the National Center for Toxicological Research 
in several studies done in conjunction with the U.S. National 
Toxicology Program (NTP) (Delclos et al. 2009; Latendresse et al. 
2009), but they still need to be integrated into standard protocols 
at the NTP, the U.S. Environmental Protection Agency (EPA), and 
the Organisation for Economic Co­operation and Development 
(OECD). Research is also needed to determine the relation  ship 
of mammary gland changes to effects on lactation and cancer 
susceptibility. The $5 million California Breast Cancer Research 
Program initiative “Making Chemicals Testing Relevant to Breast 
Cancer” is a model for stimulating research in this field, and the 
National Institute of Enironmental Health Sciences (NIEHS) 
Breast Cancer and the Environment Research Program is contribut­
ing knowledge about puberty as a critical window of develop  ment 
and susceptibility.
Although traditional cancer bioassays have identified many com­
mon pollutants that increase mammary gland tumors, including 
common air pollutants, drinking water disinfection by­products, and 
chlorinated solvents (Rudel et al. 2007), research reported in these 
three articles suggests that traditional tests that neglect develop  mental 
effects may be missing many more. Given the magnitude of potential 
public health impacts on breast­feeding and breast cancer, it is critical 
to strengthen testing methods and give more weight to them in policy 
decisions. Good decisions about pollution limits, pesticide approvals, 
and chemicals in consumer products and food rely on a full and accu­
rate understanding of risks associated with exposure. 
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